A clinical formulation indicated for Erectile Dysfunction. Enhancing blood flow in specific arterial regions, this option assists with maintaining physical performance and wellness.
A PDE5 inhibitor developed to address erectile dysfunction to support sexual activity and intended to alleviate blood flow restrictions to the penis.
Mechanism of Action
It inhibits the PDE5 enzyme, which increases cyclic GMP levels. This relaxes smooth muscle in the penile blood vessels, allowing for an erection during arousal.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
12–24 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Uncontrolled hypertension, Recent stroke
Information for Zydena is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
